-

Allosteric Bioscience, Inc. Targets Optimizing Aging and Longevity: Quantum Computing, Advanced AI, Genomics

NEW YORK--(BUSINESS WIRE)--Allosteric Bioscience, Inc. is utilizing Genetics, Genomics, Systems Biology, Quantum Computing, Advanced Proprietary AI and Proprietary Molecular Technologies for understanding and controlling the Molecular Mechanism of Aging and Longevity with the goal of optimizing the aging process and extending longevity.

Aging factors that are being targeted are Lamin A which is critical for proper cellular function, Tryptophan Metabolism involved in most aging related diseases, improved DNA repair, optimizing mitochondrial metabolism, prevention and treatment of sarcopenia (muscle wasting due to aging or weight loss drugs) and control of factors comprising a Master Aging Complex identified by Dr. Arthur P. Bollon, who is President and Co-Founder of Allosteric Bioscience, Inc.

Dr. Bollon indicates that “Creation of modulators for key controlling factors involved in the aging molecular mechanism could reduce aging related diseases and significantly extend longevity. We welcome inquires about our technologies and opportunities for collaboration and partnering”.

Contacts

Dr. Arthur P. Bollon, President and Co-Founder of Allosteric Bioscience, Inc., arthurb@flash.net, abollon@allostericbioscience.com, 469-585-7613.
Bruce Meyers, Executive Chairman and Co-Founder of Allosteric Bioscience, Inc., bmeyers@allostericbioscience.com, 469-391-7957.
www.allostericbioscience.com

Industry:

Allosteric Bioscience, Inc.

Release Versions
English

Contacts

Dr. Arthur P. Bollon, President and Co-Founder of Allosteric Bioscience, Inc., arthurb@flash.net, abollon@allostericbioscience.com, 469-585-7613.
Bruce Meyers, Executive Chairman and Co-Founder of Allosteric Bioscience, Inc., bmeyers@allostericbioscience.com, 469-391-7957.
www.allostericbioscience.com

More News From Allosteric Bioscience, Inc.

Allosteric Bioscience, Inc. Targets Extending Longevity

NEW YORK--(BUSINESS WIRE)--Allosteric Bioscience, Inc. is delineating the Molecular Mechanism of Aging and Longevity with the goal of optimizing the aging process and extending longevity. It is utilizing Genomics, Biology, Genetics, Quantum Computing, Advanced Proprietary AI and Proprietary Molecular Technologies. Select targets include Sarcopenia (muscle loss) prevention and treatment, Lamin A epigenetics, Tryptophan Metabolism, improved DNA repair, optimizing mitochondrial metabolism and cont...

Allosteric Bioscience, Inc. Licenses Sarcopenia (Muscle Loss) Prevention/Treatment Technology from Johns Hopkins University

NEW YORK--(BUSINESS WIRE)--Allosteric Bioscience, Inc. (ABI), has announced today that it has licensed technology from Johns Hopkins University for the treatment or prevention of sarcopenia which is a serious medical condition involving the loss of muscle mass, quality, and strength and is a significant part of the natural aging process. Sarcopenia can result in reduced quality of life due to falls, bone fractures, and disability. Because approximately 20% of the global population of 8.2 billio...

Allosteric Bioscience, Inc. Signs Sponsored Research Agreement with Dr. Susan Michaelis at Johns Hopkins University for Aging/Longevity-Related Work

NEW YORK--(BUSINESS WIRE)--Allosteric Bioscience, Inc. Signs a Sponsored Research Agreement with Johns Hopkins University for Aging and Longevity Related Development Work....
Back to Newsroom